Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

313.00p
   
  • Change Today:
    -7.00p
  • 52 Week High: 470.00p
  • 52 Week Low: 166.80p
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 76,983
  • Market Cap: £313.00m
  • RiskGrade: 125

Friday broker round-up

By Caoimhe Toman

Date: Friday 15 Mar 2019

LONDON (ShareCast) - (Sharecast News) - Bakkavor Group: Berenberg downgrades to sell with a target price of 105p.
Greencore: Berenberg downgrades to hold with a target price of 210p.

Kenmare Resources: Berenberg reiterates buy with a target price of 400p.

Boohoo: Shore Capital Markets reiterates buy with a target price of 178p.

Informa: Shore Capital Markets downgrades to hold.

SThree: Liberum reiterates buy with a target price of 475p.

Just Group: Deutsche Bank reiterates hold with a target price of 85p.

British American Tobacco: Deutsche Bank reiterates buy with a target price of 4,000p.

Cairn Energy: Jefferies reiterates hold with a target price of 157p.

Oxford BioMedica: Jefferies reiterates hold with a target price of 725p.

B&M: Barclays upgrades to overweight with a target price of 450p.

Cineworld Group: Barclays reiterates equal weight with a target price of 315p.

Marshalls: Peel Hunt reiterates add with a target price of 530p.

SIG: Liberum reiterates buy with a target price of 172p.

Cairn: RBC Capital Markets downgrades to sector perform with a target price of 225p.

Kainos: Canaccord reiterates buy with a target price of 590p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 313.00p
Change Today -7.00p
% Change -2.19 %
52 Week High 470.00p
52 Week Low 166.80p
Volume 76,983
Shares Issued 100.00m
Market Cap £313.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average26.86% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average
51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average51.85% above the sector average
Income Not Available
Growth
52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average52.07% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
12:21 750 @ 314.63p
12:20 5,000 @ 314.44p
12:20 55 @ 313.00p
12:18 173 @ 314.50p
12:16 649 @ 314.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page